Leticia De Mattos‐Arruda

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Leticia De Mattos‐Arruda, Regina Mayor, Charlotte K.Y. Ng et al. · Nature Communications · 2015 · 858 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

François‐Clément Bidard, Dieter Peeters, Tanja Fehm et al. · The Lancet Oncology · 2014 · 838 citations

Medicine, Cancer Biology, Oncology +17

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Javier Pascual, Gerhardt Attard, François‐Clément Bidard et al. · Annals of Oncology · 2022 · 664 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Leticia De Mattos‐Arruda, Britta Weigelt, Javier Cortés et al. · Annals of Oncology · 2014 · 378 citations · Full text

Medicine, Genetics, Oncology +16

Prognostic Impact of Pregnancy After Breast Cancer According to Estrogen Receptor Status: A Multicenter Retrospective Study

Hatem A. Azim, Niels Kroman, Marianne Paesmans et al. · Journal of Clinical Oncology · 2012 · 249 citations · Full text

Medicine, Obstetrics, Oncology +16